Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
In value terms, tirzepatide could command 30% of the drug class by 2031 if HTA bottlenecks clear and price parity tightens
This can lead to dizziness and confusion
This injectable medication is taken weekly and is a convenient addition to a personalized weight loss plan
US$ 23.83
US$ 24.03
US$ 20.79
US$ 28.45
US$ 29.76
.webp)
US$ 24.47
US$ 27.91
US$ 27.66
US$ 25.99
US$ 26.36
US$ 28.40
